NDC 12854-432
Insulin Glargine Solostar
Insulin Glargine
Insulin Glargine Solostar is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis Deutschland Gmbh. The primary component is Insulin Glargine.
| Product ID | 12854-432_e67caa0a-67ab-febd-e053-2995a90ab343 |
| NDC | 12854-432 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Glargine Solostar |
| Generic Name | Insulin Glargine |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-05-02 |
| Marketing Category | BLA / |
| Application Number | BLA021081 |
| Labeler Name | Sanofi-Aventis Deutschland GmbH |
| Substance Name | INSULIN GLARGINE |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin Analog [EPC], Insulin [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |